The University of Chicago Header Logo

Connection

Tong-Chuan He to Growth Differentiation Factor 2

Back to Details
This is a "connection" page, showing publications Tong-Chuan He has written about Growth Differentiation Factor 2.
Tong-Chuan He
Connection Strength
7.670
Growth Differentiation Factor 2
  1. Leptin Potentiates BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Through the Activation of JAK/STAT Signaling. Stem Cells Dev. 2020 04 15; 29(8):498-510.
    View in: PubMed
    Score: 0.684
  2. lncRNA Rmst acts as an important mediator of BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) by antagonizing Notch-targeting microRNAs. Aging (Albany NY). 2019 12 11; 11(24):12476-12496.
    View in: PubMed
    Score: 0.673
  3. Characterization of scaffold carriers for BMP9-transduced osteoblastic progenitor cells in bone regeneration. J Biomed Mater Res A. 2014 Oct; 102(10):3429-38.
    View in: PubMed
    Score: 0.440
  4. Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells. J Bone Miner Res. 2012 Jul; 27(7):1566-75.
    View in: PubMed
    Score: 0.401
  5. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. Curr Gene Ther. 2011 Jun; 11(3):229-40.
    View in: PubMed
    Score: 0.372
  6. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J Biol Chem. 2010 Sep 17; 285(38):29588-98.
    View in: PubMed
    Score: 0.350
  7. Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. J Biol Chem. 2009 Jan 02; 284(1):649-659.
    View in: PubMed
    Score: 0.312
  8. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med. 2009 Aug; 13(8B):2448-2464.
    View in: PubMed
    Score: 0.312
  9. Reversely immortalized mouse salivary gland cells presented a promising metabolic and fibrotic response upon BMP9/Gdf2 stimulation. Cell Mol Biol Lett. 2022 Jun 11; 27(1):46.
    View in: PubMed
    Score: 0.200
  10. BMP9-initiated osteogenic/odontogenic differentiation of mouse tooth germ mesenchymal cells (TGMCS) requires Wnt/ß-catenin signalling activity. J Cell Mol Med. 2021 03; 25(5):2666-2678.
    View in: PubMed
    Score: 0.183
  11. Differential Responsiveness to BMP9 between Patent and Fused Suture Progenitor Cells from Craniosynostosis Patients. Plast Reconstr Surg. 2020 03; 145(3):552e-562e.
    View in: PubMed
    Score: 0.171
  12. Imiquimod Acts Synergistically with BMP9 through the Notch Pathway as an Osteoinductive Agent In Vitro. Plast Reconstr Surg. 2019 11; 144(5):1094-1103.
    View in: PubMed
    Score: 0.167
  13. Dentinogenesis and Tooth-Alveolar Bone Complex Defects in BMP9/GDF2 Knockout Mice. Stem Cells Dev. 2019 05 15; 28(10):683-694.
    View in: PubMed
    Score: 0.160
  14. BMP9-induced osteoblastic differentiation requires functional Notch signaling in mesenchymal stem cells. Lab Invest. 2019 01; 99(1):58-71.
    View in: PubMed
    Score: 0.155
  15. Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation. J Cell Biochem. 2018 11; 119(11):8872-8886.
    View in: PubMed
    Score: 0.153
  16. Inhibitory effects of BMP9 on breast cancer cells by regulating their interaction with pre-adipocytes/adipocytes. Oncotarget. 2017 May 30; 8(22):35890-35901.
    View in: PubMed
    Score: 0.141
  17. BMP9 induces osteogenesis and adipogenesis in the immortalized human cranial suture progenitors from the patent sutures of craniosynostosis patients. J Cell Mol Med. 2017 Nov; 21(11):2782-2795.
    View in: PubMed
    Score: 0.140
  18. Engineering the Rapid Adenovirus Production and Amplification (RAPA) Cell Line to Expedite the Generation of Recombinant Adenoviruses. Cell Physiol Biochem. 2017; 41(6):2383-2398.
    View in: PubMed
    Score: 0.140
  19. Notch Signaling Augments BMP9-Induced Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells (MSCs). Cell Physiol Biochem. 2017; 41(5):1905-1923.
    View in: PubMed
    Score: 0.140
  20. NEL-Like Molecule-1 (Nell1) Is Regulated by Bone Morphogenetic Protein 9 (BMP9) and Potentiates BMP9-Induced Osteogenic Differentiation at the Expense of Adipogenesis in Mesenchymal Stem Cells. Cell Physiol Biochem. 2017; 41(2):484-500.
    View in: PubMed
    Score: 0.138
  21. A thermoresponsive polydiolcitrate-gelatin scaffold and delivery system mediates effective bone formation from BMP9-transduced mesenchymal stem cells. Biomed Mater. 2016 Apr 21; 11(2):025021.
    View in: PubMed
    Score: 0.131
  22. The Prodomain-Containing BMP9 Produced from a Stable Line Effectively Regulates the Differentiation of Mesenchymal Stem Cells. Int J Med Sci. 2016; 13(1):8-18.
    View in: PubMed
    Score: 0.128
  23. Hedgehog signaling is involved in the BMP9-induced osteogenic differentiation of mesenchymal stem cells. Int J Mol Med. 2015 Jun; 35(6):1641-50.
    View in: PubMed
    Score: 0.122
  24. Activation of PKA/CREB Signaling is Involved in BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells. Cell Physiol Biochem. 2015; 37(2):548-62.
    View in: PubMed
    Score: 0.119
  25. A simplified and versatile system for the simultaneous expression of multiple siRNAs in mammalian cells using Gibson DNA Assembly. PLoS One. 2014; 9(11):e113064.
    View in: PubMed
    Score: 0.118
  26. Bone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla. Stem Cells Dev. 2014 Jun 15; 23(12):1405-16.
    View in: PubMed
    Score: 0.113
  27. Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling. Curr Cancer Drug Targets. 2014; 14(3):274-85.
    View in: PubMed
    Score: 0.111
  28. Endoplasmic reticulum (ER) stress inducible factor cysteine-rich with EGF-like domains 2 (Creld2) is an important mediator of BMP9-regulated osteogenic differentiation of mesenchymal stem cells. PLoS One. 2013; 8(9):e73086.
    View in: PubMed
    Score: 0.109
  29. Inhibition of histone deacetylases potentiates BMP9-induced osteogenic signaling in mouse mesenchymal stem cells. Cell Physiol Biochem. 2013; 32(2):486-98.
    View in: PubMed
    Score: 0.109
  30. Cross-talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cells. J Cell Mol Med. 2013 Sep; 17(9):1160-72.
    View in: PubMed
    Score: 0.108
  31. BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J Cell Sci. 2013 Jan 15; 126(Pt 2):532-41.
    View in: PubMed
    Score: 0.103
  32. Biphasic effects of TGFß1 on BMP9-induced osteogenic differentiation of mesenchymal stem cells. BMB Rep. 2012 Sep; 45(9):509-14.
    View in: PubMed
    Score: 0.102
  33. Conditionally immortalized mouse embryonic fibroblasts retain proliferative activity without compromising multipotent differentiation potential. PLoS One. 2012; 7(2):e32428.
    View in: PubMed
    Score: 0.098
  34. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010 Nov; 25(11):2447-59.
    View in: PubMed
    Score: 0.089
  35. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One. 2010 Jul 30; 5(7):e11917.
    View in: PubMed
    Score: 0.088
  36. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 2007 May; 25(5):665-77.
    View in: PubMed
    Score: 0.070
  37. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004 Dec 31; 279(53):55958-68.
    View in: PubMed
    Score: 0.059
  38. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004 Jul 30; 279(31):32941-9.
    View in: PubMed
    Score: 0.057
  39. Long non-coding RNA (LncRNA) HOTAIR regulates BMP9-induced osteogenic differentiation by targeting the proliferation of mesenchymal stem cells (MSCs). Aging (Albany NY). 2021 01 10; 13(3):4199-4214.
    View in: PubMed
    Score: 0.045
  40. Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells. ACS Synth Biol. 2019 09 20; 8(9):2092-2105.
    View in: PubMed
    Score: 0.041
  41. A simplified 3D liver microsphere tissue culture model for hepatic cell signaling and drug-induced hepatotoxicity studies. Int J Mol Med. 2019 Nov; 44(5):1653-1666.
    View in: PubMed
    Score: 0.041
  42. BMP9 Promotes the Proliferation and Migration of Bladder Cancer Cells through Up-Regulating lncRNA UCA1. Int J Mol Sci. 2018 Apr 08; 19(4).
    View in: PubMed
    Score: 0.037
  43. Gelatin-Derived Graphene-Silicate Hybrid Materials Are Biocompatible and Synergistically Promote BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells. ACS Appl Mater Interfaces. 2017 May 17; 9(19):15922-15932.
    View in: PubMed
    Score: 0.035
  44. Repair of critical sized cranial defects with BMP9-transduced calvarial cells delivered in a thermoresponsive scaffold. PLoS One. 2017; 12(3):e0172327.
    View in: PubMed
    Score: 0.035
  45. Nanoparticulate Mineralized Collagen Scaffolds and BMP-9 Induce a Long-Term Bone Cartilage Construct in Human Mesenchymal Stem Cells. Adv Healthc Mater. 2016 07; 5(14):1821-30.
    View in: PubMed
    Score: 0.033
  46. BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells. Cell Oncol (Dordr). 2014 Oct; 37(5):363-75.
    View in: PubMed
    Score: 0.029
  47. BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways. PLoS One. 2014; 9(5):e96816.
    View in: PubMed
    Score: 0.029
  48. BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression. Mol Biol Rep. 2014 Mar; 41(3):1373-83.
    View in: PubMed
    Score: 0.028
  49. Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells. J Orthop Res. 2013 Nov; 31(11):1796-803.
    View in: PubMed
    Score: 0.027
  50. BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231. J Cancer Res Clin Oncol. 2011 Nov; 137(11):1687-96.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.